December 29, 2024 - 15:52

TORONTO — As 2024 unfolded, key questions loomed over Canadian finance, primarily centered around the potential for an economic recession and the trajectory of interest rates. Throughout the year, the Canadian economy demonstrated resilience, largely driven by robust consumer spending and a steady job market. Despite global uncertainties, including fluctuating commodity prices and geopolitical tensions, Canada managed to maintain a moderate growth rate.
Interest rates became a focal point for both policymakers and consumers, as the Bank of Canada navigated the challenges of inflation while striving to support economic stability. The central bank's decisions were closely monitored, with many analysts predicting a cautious approach to rate adjustments. This balancing act aimed to foster growth without exacerbating inflationary pressures.
Investors remained vigilant, adjusting their strategies in response to changing market conditions. Overall, 2024 proved to be a pivotal year for Canadian finance, characterized by a blend of challenges and opportunities that shaped the financial landscape for years to come.
March 15, 2026 - 03:23
Audit finds strong oversight at Fort Worth Housing Finance Corp, flags minor control gapsA recent operational audit of the Fort Worth Housing Finance Corporation has concluded that the agency maintains strong overall oversight, though it identified a handful of minor internal control...
March 14, 2026 - 07:39
Nvidia GTC, Macy's earnings, FOMC meeting: What to WatchThe upcoming week presents a critical lineup of events for the financial markets, with major corporate developments and a key Federal Reserve meeting on the calendar. All eyes will be on the...
March 13, 2026 - 20:57
Richard Donoff Encourages Americans to Prioritize Long-Term Financial PreparednessIn a recent address, financial expert Richard Donoff emphasized the critical need for American families to shift their focus toward long-term financial preparedness. He advocates for a proactive...
March 13, 2026 - 04:55
Capricor Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate UpdateCapricor Therapeutics has announced its financial results for the fourth quarter and full year 2025, alongside significant progress in its lead clinical program. The company`s Biologics License...